(Q40520302)

21 September 2017

1 reference

title

Markers supplementing CA 125 in ovarian cancer (English)

1 reference

Mucin 16, cell surface associated

21 September 2017

main subject

1 reference

Stenman UH

1

1 reference

21 September 2017

Alfthan H

series ordinal

2

1 reference

21 September 2017

Vartiainen J

series ordinal

3

1 reference

21 September 2017

Lehtovirta P

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

21 September 2017

1 reference

21 September 2017

volume

27

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

115-120

1 reference

The clinical significance of carcinoembryonic antigen in the plasma and tumors of patients with gynecologic malignancies

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

CA 125 in gynecological pathology--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Tumour-associated trypsin inhibitor (TATI) in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Ectopic Production of Human Chorionic Gonadotrophin by Neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Polymorphism of protein and polypeptide hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Characterisation of UGP and its relationship with beta-core fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031946

10.3109/07853899509031946

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference